Ligands for the common allosteric site of acetylcholine M2-receptors: Development and application

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 149-155

  Holzgrabe, U ^a   Bender, W ^a   Botero Cid, H M ^a   Staudt, M ^a   Pick, R ^a   Pfletschinger, C ^a   Balatkova E ^b   Trankle C ^b   Mohr, K ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

3D QSAR analysis; Acetylcholine M2 receptor; Allosteric modulation; Allosteric site; Dementia; N methylscopolamine; Organophosphorus poisoning; Pain; W84

Indexed keywords

MUSCARINIC M2 RECEPTOR; PHTHALIMIDE DERIVATIVE;

BINDING AFFINITY; BINDING SITE; CONFERENCE PAPER; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; LIPOPHILICITY; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALS; CHOLINERGIC AGENTS; HUMANS; LIGANDS; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034078073     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00028-X     Document Type: Conference Paper

References (19)

1. Andrews, P.R., 1993. Drug-receptor interactions. In: Kubinyi, H. (Ed.), 3D QSAR in Drug Design - Theory Methods and Applications. ESCOM, Leiden, pp. 13-40.
2. 2-receptors. Life Science, in press.
3. Birdsall N.J.M., Farries T., Gharagozloo P., Kobayashi S., Lazareno S., Sugimoto M. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies. Mol. Pharmacol. 4:1999;778-787.
4. Böhm H.-J., Klebe G. Was läßt sich aus der molekularen Erkennung in Protein-Ligand-Komplexen für das Drug-Design neuer Wirkstoffe lernen? Angew. Chem. Int. Ed. Engl. 35:1996;2588-2614.
5. 2-receptor allosterically. J. Med. Chem., submitted.
6. Choo L.K., Mitchelson F. Characterization of the antimuscarinic effect of heptane-1,7-bis(dimethyl-3′-phthalimidopropyl ammonium bromide. Eur. J. Pharmacol. 162:1989;429-435.
7. Christopoulos A., Lanzafame A., Mitchelson F. Allosteric interactions of muscarinic cholinoceptos. Clin. Exp. Pharmacol. Physiol. 25:1998;185-194.
8. Gharagozloo P., Lazareno S., Popham A., Birdsall N.J. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors. J. Med. Chem. 42:1999;438-445.
9. Holzgrabe U., Hopfinger A.J. Conformational analysis, molecular shape comparison and pharmacophore identification of different allosteric modulators of muscarinic receptors. J. Chem. Inf. Comp. Sci. 36:1996;1018-1024.
10. Holzgrabe U., Mohr K. Allosteric modulation of antagonist binding to muscarinic receptors. Drug Discovery Today. 3:1998;214-222.
11. 2-cholinoceptors. J. Mol. Graph. 14:1996;185-193.
12. 2-receptor: unilateral structural variations of alkane bisammonium-type modulators. Abstract DPhG and SGPhW Symposium, Zürich.
13. 3H -N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication Pharmacol. Toxicol. 63:1988;163-168.
14. Koolman, J., Röhm, K.-H., 1996. Color Atlas of Biochemistry. Thieme Verlag, Stuttgart, pp. 107-108.
15. 2-cholinoceptors of derivatives of the alkane-bis-ammonium compound W84 - comparison with bispyridinium-type allosteric modulators. Eur. J. Med. Chem. 29:1994;947-953.
16. 2 acetylcholine receptors: optimization of the distances between the pharmacophoric elements. J. Med. Chem. 42:1999;849-858.
17. 2 receptors. Mol. Pharmacol. 51:1997;674-682.
18. Tränkle C., Kostenis E., Burgmer U., Mohr K. Search for lead structures to develop new allosteric modulators of muscarinic receptors. J. Pharmacol. Exp. Ther. 279:1996;926-933.
19. 2 receptors Mol. Pharmacol. 54:1998;139-145.